Dr. Amanda Nelson has received certification in Musculoskeletal Ultrasound in Rheumatology through the American College of Rheumatology RhMSUS program. This certification requires extensive training, practice, and successful completion of a comprehensive examination. Dr. Nelson previously completed the Train-the Trainer program through USSONAR (Ultrasound School of North American Rheumatologists) and the ACR. She was a speaker and small group mentor for the Duke Musculoskeletal Ultrasound in Rheumatology Training course in 2013, and now serves as a mentor for the USSONAR online training program. She provides didactic and hands-on training in musculoskeletal ultrasound for our Rheumatology fellows, and staffs a half-day ultrasound clinic at the Farrington Road Rheumatology clinic site.
You can also check out the announcement of the Multidisciplinary Clinical Research Center (MCRC) grant on these media outlet websites:
"I am thrilled to join the faculty at UNC and the Thurston Arthritis Research Center. I look forward to continuing the advancement of the center's mission by providing state-of-the-art care to our patients and constantly striving to bring new and innovative treatment approaches to our patients. As a clinical immunologist with dual training in Allergy, Immunology & Rheumatology, I am privileged to have the opportunity to take care of patients with a wide range of allergic, immunologic and rheumatologic diseases. "
When she isn't working, Dr. Sheikh loves spending time with her husband and four year old son. As a family, they travel around the world and are always looking for new places to visit and explore.
Please join us in giving a warm welcome to Dr. Sheikh!
This 5-year grant will establish our Center as the hub for Osteoarthritis (OA) research on campus and includes a Methodology Core devoted to helping all projects in the Center be successful, discrete teaching on study design and biostatistics, and seminars, among other things.
Joanne Jordan, MD MPH is the Primary Investigator and Director of the Multidisciplinary Clinical Research Center and Leigh Callahan, PhD is the Associate Director. Todd Schwartz, DrPH will be chairing the Methodology Core, with Bob DeVellis, PhD as consultant.
Two projects, utilizing two UNC gems, The Johnston County Osteoarthritis Project and the JUMP-ACL study, will be led by Drs. Chris Rini and Steve Marshall, respectively. Dr. Rini's study will be looking at people with OA and how a significant other/support person can help with increasing the person's physical activity. The second study will be following military cadets with who have sustained an ACL tear for the development of early OA.
*NIAMS - National Institute of Arthritis and Musculoskeletal and Skin Diseases
Dr. Kim served as the 2013 Medical Chair of the Triangle FARE Walk for Food Allergy on September 28, 2013. Almost 500 people attended the Walk, raising $27,000! The Thurston Arthritis Research Center was proud to sponsor the Triangle FARE Walk for Food Allergy in support of Dr. Kim. The treatment of and investigation of cures for food allergies are very important to Dr. Kim. Congratulations to Dr. Kim on this honor!
Breast cancer is the second most common cancer among women in the U.S., with an estimated 207,090 new diagnoses in 2010 and a lifetime risk among women born today of 1 in 8. Most breast cancer cases are diagnosed among postmenopausal women at an early and treatable stage, and most of their tumors (70-80%) are hormone-receptor positive. For these women, standard adjuvant endocrine treatment is aromatase inhibitor (AI) therapy to prolong disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/ achiness is a common side-effect of AIs, with estimates of joint complaints ranging from 46% to 74% among survivors seen in clinical practice. The precise etiology of AI-associated musculoskeletal symptoms (AIMSS) remains unclear and is complicated by the high prevalence of benign and non-specific musculoskeletal symptoms in the general population of older women, such as arthritis. AI discontinuation due to side-effect severity is an estimated 20-32%, and is of great concern among oncologists. Research is needed to identify effective, easy-to-use, sustainable, and safe alternative or adjunct approaches to AIMSS management, so that breast cancer survivors are able to remain on AI therapy and have a life that is as pain-free as possible.
The Callahan team will investigate whether moderate-intensive physical activity (PA) can provide relief from AIMSS within a sample of female breast cancer survivors on AI therapy who report moderate to severe joint symptoms. Specifically, they will adapt and test the Arthritis Foundation’s Walk With Ease (WWE) program, which is evidence-based for reducing joint pain, stiffness and fatigue among adults with arthritis and is available in a self-directed (non-group) format. All aspects of this study will be informed by Patient Advisors who are part of the Study Team as well as by oncologists who are actively engaged in the design, implementation and analysis of the program.